196 related articles for article (PubMed ID: 17119503)
1. [The dopaminergic hypothesis revisited].
Guillin O
Encephale; 2006 Oct; 32(5 Pt 4):S908-11; discussion S912. PubMed ID: 17119503
[No Abstract] [Full Text] [Related]
2. Recent evidence for dopamine abnormalities in schizophrenia.
Abi-Dargham A
Eur Psychiatry; 2002 Aug; 17 Suppl 4():341s-347s. PubMed ID: 23573603
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia: a computational reinforcement learning perspective.
Frank MJ
Schizophr Bull; 2008 Nov; 34(6):1008-11. PubMed ID: 18791075
[No Abstract] [Full Text] [Related]
4. D1 and D2 and D3.
Healy D
Br J Psychiatry; 1991 Sep; 159():319-24. PubMed ID: 1683592
[No Abstract] [Full Text] [Related]
5. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
[TBL] [Abstract][Full Text] [Related]
6. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
Guise S; Soubrouillard C; Blin O
Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
[TBL] [Abstract][Full Text] [Related]
7. Antipsychotic drug mechanisms and neurotransmitter systems in schizophrenia.
Reynolds GP
Acta Psychiatr Scand Suppl; 1994; 380():36-40. PubMed ID: 7914046
[TBL] [Abstract][Full Text] [Related]
8. Occupancy of striatal dopamine D2 receptors.
Baron JC
Psychiatry Res; 1995 Nov; 61(4):285-7. PubMed ID: 8748471
[No Abstract] [Full Text] [Related]
9. [The involvement of D-1 and D-2 dopamine receptors in the effects of neuroleptics and the pathogenesis of schizophrenia].
Wielgosz M
Psychiatr Pol; 1992; 26(5):357-64. PubMed ID: 1363827
[TBL] [Abstract][Full Text] [Related]
10. Frontal fasciculi and psychotic symptoms in antipsychotic-naive patients with schizophrenia before and after 6 weeks of selective dopamine D2/3 receptor blockade.
Ebdrup BH; Raghava JM; Nielsen MØ; Rostrup E; Glenthøj B
J Psychiatry Neurosci; 2016 Mar; 41(2):133-41. PubMed ID: 26599135
[TBL] [Abstract][Full Text] [Related]
11. Plasma prolactin and central D2 receptor occupancy in antipsychotic drug-treated patients.
Nordström AL; Farde L
J Clin Psychopharmacol; 1998 Aug; 18(4):305-10. PubMed ID: 9690696
[TBL] [Abstract][Full Text] [Related]
12. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
Singh AN; Barlas C; Saeedi H; Mishra RK
J Psychiatry Neurosci; 2003 Jan; 28(1):39-47. PubMed ID: 12587849
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.
Howes OD; Egerton A; Allan V; McGuire P; Stokes P; Kapur S
Curr Pharm Des; 2009; 15(22):2550-9. PubMed ID: 19689327
[TBL] [Abstract][Full Text] [Related]
14. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
[TBL] [Abstract][Full Text] [Related]
15. Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.
Geaney DP; Ellis PM; Soper N; Shepstone BJ; Cowen PJ
Biol Psychiatry; 1992 Aug; 32(3):293-5. PubMed ID: 1358229
[No Abstract] [Full Text] [Related]
16. [Pharmacology of antipsychotic drugs]].
Bourin M
Encephale; 2006 Jan; 32 Pt 2():S8-9. PubMed ID: 16800078
[No Abstract] [Full Text] [Related]
17. Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.
Agid O; Mamo D; Ginovart N; Vitcu I; Wilson AA; Zipursky RB; Kapur S
Neuropsychopharmacology; 2007 Jun; 32(6):1209-15. PubMed ID: 17077809
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone.
Busatto GF; Pilowsky LS; Ell PJ; Costa DC; Verhoeff NP; Kerwin RW
Br J Psychiatry; 1993 Dec; 163():833-4. PubMed ID: 7508329
[No Abstract] [Full Text] [Related]
19. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
20. Review the role of dopamine D4 receptors in schizophrenia and antipsychotic action.
Sanyal S; Van Tol HH
J Psychiatr Res; 1997; 31(2):219-32. PubMed ID: 9278187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
